The Scientist

» aging and developmental biology

Most Recent

image: From Many, One

From Many, One

By | April 1, 2015

Diverse mammals, including humans, have been found to carry distinct genomes in their cells. What does such genetic chimerism mean for health and disease?

4 Comments

image: Short, Strong Signals

Short, Strong Signals

By | March 25, 2015

Methylation increases both the activity and instability of the signaling protein Notch.

0 Comments

image: Opinion: Can the Brain Be Trained?

Opinion: Can the Brain Be Trained?

By | March 23, 2015

Online brain-training is gaining popularity, but so far little evidence exists to support claims of improved cognition.

5 Comments

image: Age-Old Questions

Age-Old Questions

By | March 1, 2015

How do we age, and can we slow it down?

1 Comment

image: As the Brain Ages

As the Brain Ages

By | March 1, 2015

See human brains age in week-by-week time lapse images that divulge the existence of tiny strokes that damage white matter.

2 Comments

image: Contributors

Contributors

By | March 1, 2015

Meet some of the people featured in the March 2015 issue of The Scientist.

0 Comments

image: Growth Hormone Guidance

Growth Hormone Guidance

By | March 1, 2015

Intact growth hormone signaling pathways are needed for methionine restriction to extend mouse lifespan.

0 Comments

image: Long Live Collagen

Long Live Collagen

By | March 1, 2015

Increased collagen expression is a common feature of many different pathways to extended longevity in worms.

3 Comments

image: Of Cells and Limits

Of Cells and Limits

By | March 1, 2015

Leonard Hayflick has been unafraid to speak his mind, whether it is to upend a well-entrenched dogma or to challenge the federal government. At 86, he’s nowhere near retirement.

3 Comments

image: Quantity or Quality?

Quantity or Quality?

By | March 1, 2015

Living longer doesn’t necessarily mean living healthier.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech